Hence, we propose that SOX2OT alleviates cell proliferation and fibrosis in DN by regulating Akt/mTOR-mediated autophagy, indicating that SOX2OT may represent a novel target for DN treatment. The gene discussed is MTOR; the disease is liver dysplastic nodule.